After a mesothelioma diagnosis, further testing is required to determine the stage of the cancer. Depending on the
type of mesothelioma,
different methods of testing may be used. Diagnostic tools assess
whether the cancer is in Stage I, Stage II, Stage III or Stage IV.
The most common staging tools are x-rays, computed tomography scan (CT) or a magnetic resonance imaging scan (MRI).
In cases of pleural mesothelioma, bronchoscopy allows oncologists to
have a visual image of the airways and bronchi, to help determine the
stage that the cancer has advanced to.
There are three
mesothelioma staging systems typically used by physicians: TNM Classification of Malignant Tumors, Butchart Staging System and the Brigham Staging System.
TNM is the most common grading system for all types of mesothelioma
in which “T” refers to the size of the tumor; “N” if the lymph nodes are
involved; and “M” whether the has cancer metastasized to other organs.
The Butchart Staging System, used mainly for pleural mesothelioma, determines the size and metastases of the mesothelioma.
Staging designation within the Brigham Staging System is based on whether or not the
mesothelioma is operable and whether the lymphatic system is involved.
What is Stage I Mesothelioma?
Within the range of progressive staging metrics,
Stage I Mesothelioma
is the most treatable form of the disease. Stage I mesothelioma is an
extremely rare diagnosis, however, as symptoms do not usually present
until after the disease has progressed to advanced stages.
Stage I mesothelioma is classified in cases where the cancer is
localized to a specific region – lungs, heart or abdomen – and has not
yet metastasized to other organs or reached the lymphatic system.
With pericardial or peritoneal mesothelioma, the cancer has yet to breach the lining of the heart or abdomen.
Stage I Mesothelioma is typically operable and treatable with chemotherapy or radiation but as mentioned earlier, is rare.
What are the Common Treatments for Stage I Mesothelioma?
The range of
Mesothelioma treatment
options available for Stage I patients is the broadest available
because, at this stage, the cancer is still localized. Conventional
treatments and / or participation in clinical trials are most often
recommended for patients presenting with early stages of mesothelioma.
For Stage I Mesothelioma,
surgery
is the first treatment option explored, and in most cases, it is
usually the best option. Surgery removes the affected lining around the
lungs, heart or abdomen.
Typically used in conjunction with surgery and chemotherapy,
radiation
is a common treatment method for Stage I Mesothelioma. Radiation
therapy targets and controls the metastases of cancerous cells. By
destroying cancerous cells, radiation therapy inhibits the spread of
mesothelioma. Though there are some side effects associated with the
treatment, like fatigue and joint pain, radiation therapy usually yields
positive results for Stage I Mesothelioma.
Another common treatment option for Stage I Mesothelioma is
chemotherapy.
By administering high doses of specific medications, chemotherapy
targets the cancerous cells and destroys them. With chemotherapy,
however, the side effects of the treatment can be worse than the
symptoms of the cancer itself.
Hyperthermia and Chemotherapy
Recent studies have shown that cancerous cells are more responsive to
chemotherapy in cases of hyperthermia due to the increase of body
temperature. Currently this treatment modality shows only a minimal
impact on overall life expectancy and is still in its infancy.
A breakthrough in carcinoma treatment, gene therapy involves
implantation of healthy genes that target cancerous cells. Though not
commonly used for Stage I Mesothelioma, gene therapy is a growing
treatment for several types of cancer, and is under going further
research.
By “enhancing” the immune system’s ability to fight off disease,
immunotherapy is showing some promise for treating Stage I Mesothelioma.
Through intravenous immune-enhancing drugs, the immune system is
“jump-started” to attack invading cancerous cells. Research for this
type of treatment is still ongoing and results, thus far, are
inconclusive as to whether immunotherapy is a viable option for Stage I
Mesothelioma.
For some mesothelioma patients, taking part in a clinical trial may
be the best option. Clinical trials often test treatment and drug
options on mesothelioma patients that have already undergone vigorous
scientific testing. Many clinical trials use a placebo as a control, and
mesothelioma patients should consult with their doctor to understand
the risk involved before entering any trial.